Sumatriptan Spray
Product Images NDC 0527-1818

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 0527-1818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Suumatriptan-molec-struc (Sumatriptan Nasal Spray Usp 1)

FDA Label Image

5mg-cl-front (Sumatriptan Nasal Spray Usp 10)

FDA Label Image

5mg-cl-back (Sumatriptan Nasal Spray Usp 11)

FDA Label Image

5mg-blister (Sumatriptan Nasal Spray Usp 12)

This is a description of Sumatriptan nasal spray which contains 5mg of sumatriptan. It is intended for intranasal use only and comes in a unit dose spray. The inactive ingredients include purified water, sulfuric acid, sodium hydroxide, monobasic potassium phosphate, and anhydrous dibasic sodium phosphate. The package insert contains full prescribing information and the product should be stored between 36°F and 86°F (2°C and 30°C) and protected from light. It was manufactured by Summit Bosciences Inc. in Lexington, KY for Famet oy in Philadelphia, PA.*

FDA Label Image

5mg-carton (Sumatriptan Nasal Spray Usp 13)

Sumatriptan Nasal Spray, USP, is a medication for intranasal use only. Each package contains six nasal spray units, with 0.1 mL per unit, and each unit dose nasal spray contains 5 mg of sumatriptan. The inactive ingredients include purified water, sulfuric acid, sodium hydroxide, monobasic potassium phosphate, and anhydrous dibasic sodium phosphate. The medication is stored between 36° and 86°F (2° and 30°C) and should be protected from light. Dosage information should be obtained from a prescribing information sheet. The package should not be tested before use. The medication is manufactured for Lannett Company, Inc., and manufactured by Summit Biosciences Inc. at Lexington, KY 40511.*

FDA Label Image

20mg-cl-front (Sumatriptan Nasal Spray Usp 14)

FDA Label Image

20mg-cl-back (Sumatriptan Nasal Spray Usp 15)

FDA Label Image

20mg-blister (Sumatriptan Nasal Spray Usp 16)

Sumatriptan Nasal Spray, USP is a medication used for intranasal use only. Each unit dose spray contains 20 mg of sumatriptan. The spray should not be tested before use and should be stored between 36°F and 86°F (2°C and 30°0). The medication should be kept away from light. The nasal spray is manufactured by Summit Bosdiences in Leangton, KY 40511, and is packaged by Famet Company in Philadelphia, PA. The inactive ingredients include purified water, sulfuric acid, sodium hydroxide, monobasic potassium phosphate, and anhydrous dibasic sodium phosphate. The full prescribing information is available in the package insert.*

FDA Label Image

20mg-carton (Sumatriptan Nasal Spray Usp 17)

Sumatriptan Nasal Spray is a medication used for intranasal use only. It comes in six nasal spray unit doses, with 0.1 mL per unit. Each unit contains 20 mg of sumatriptan along with purified water, sulfuric acid, sodium hydroxide, monobasic potassium phosphate, anhydrous dibasic sodium phosphate as inactive ingredients. The medication needs to be stored between 36° and 86°F (2° and 30°C) and should be protected from light. The dosage information can be found in the prescribing information. The product is manufactured both by Lannett Company, Inc. located in Philadelphia, PA 19136 and Summit Biosciences Inc. in Lexington, KY 40511.*

FDA Label Image

Figure1 (Sumatriptan Nasal Spray Usp 2)

This appears to be a graph showing the estimated probability of a response to a treatment over time, with different doses and a placebo being compared. It seems that the x-axis represents time in minutes from the initial dose, while the y-axis represents the percentage of patients who responded to the treatment at a given time point. More information about the treatment and the study would be necessary to fully understand this graph.*

FDA Label Image

Figure2 (Sumatriptan Nasal Spray Usp 3)

FDA Label Image

Figa (Sumatriptan Nasal Spray Usp 4)

FDA Label Image

Figb (Sumatriptan Nasal Spray Usp 5)

FDA Label Image

Figc (Sumatriptan Nasal Spray Usp 6)

FDA Label Image

Figd (Sumatriptan Nasal Spray Usp 7)

FDA Label Image

Fige (Sumatriptan Nasal Spray Usp 8)

FDA Label Image

Figf (Sumatriptan Nasal Spray Usp 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.